Advancing new research

The Interlaken Leadership Awards

About ILA


Immunoglobulin therapy has a wide range of indications, from the treatment of immunodeficiencies to the control of autoimmune and inflammatory diseases. The number of potential applications for immunoglobulin therapy continues to expand, and recent research has highlighted several promising novel uses.

To demonstrate its continued commitment to innovative immunoglobulin research, CSL Behring has created the Interlaken Leadership Awards.

Mission statement

The Interlaken Leadership Awards program was created to meet the following objectives:

  • To identify new clinical applications for immunoglobulin therapy in the neurology field
  • To further investigate the efficacy, mechanisms of action, and treatment optimization of polyvalent immunoglobulins

Program focus

The current focus of the Interlaken Leadership Awards program is to advance medical research and knowledge about the potential role of immunoglobulin therapy in the treatment of neurological disorders.

About CSL Behring

CSL Behring is a global leader in the plasma protein biotherapeutics industry. We research, develop, manufacture and market biotherapies that are used to treat serious and rare conditions. Users of our therapies rely on them for their quality of life and, in many cases, for life itself.

Our commitment to saving lives and improving the quality of life for people with serious and rare conditions is evident in everything we do. Whether we are manufacturing and marketing safe and effective products or researching and developing innovative biotherapies, we are first and foremost focused on fulfilling our customers’ needs.

For more than a century, CSL Behring has been providing safe, effective therapies to help improve the lives of people affected by rare and serious medical conditions. In 1978 we produced the world’s first intact (unmodified) human IVIG and then in 1999 was the first to manufacture chromatographically purified IVIG. Today, CSL Behring continues to demonstrate its commitment to immunoglobulin research by sponsoring the International Immunoglobulin Conference and the Interlaken Leadership Awards.